RecruitingPhase 3NCT06579573

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

ONO-2017 Phase III Study A Multicenter, Open-label Study in Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Sponsor

Ono Pharmaceutical Co., Ltd.

Enrollment

15 participants

Start Date

Jul 12, 2022

Study Type

INTERVENTIONAL

Conditions

Epilepsy, Generalized

Summary

To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.

Eligibility

Min Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cenobamate for people with epilepsy, generalized. The study is currently recruiting participants at 25 locations. People eligible for this study include aged 12 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCenobamate

Cenobamate will be orally administered once daily.

Locations(25)

Aichi Medical University Hospital

Aichi, Japan

Hospital of the University of Occupational and Environmental Health, Japan

Fukuoka, Japan

Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU Medical Clinic

Fukushima, Japan

Local Independent Administrative Corporation Hiroshima City Hospital Organization Hiroshima City Hiroshima Citizens Hospital

Hiroshima, Japan

Hokkaido University Hospital

Hokkaido, Japan

Itami City Hospital

Hyōgo, Japan

Tsuchiura Kyodo General Hospita

Ibaraki, Japan

University of Tsukuba Hospital

Ibaraki, Japan

Kagoshima University Hospital

Kagoshima, Japan

SHOWA University Fujigaoka Hospital

Kanagawa, Japan

Yokohama City University Hospital

Kanagawa, Japan

National Hospital Organization Nishiniigata Chuo Hospital

Niigata, Japan

Koide Clinic of Epilepsy and Neurological Disorders

Osaka, Japan

TMG Asaka Medical Center

Saitama, Japan

NHO Shizuoka Institute of Epilepsy and Neurological Disorder

Shizuoka, Japan

Jichi Medical University Hospital

Tochigi, Japan

Jikei University Hospital

Tokyo, Japan

Maynds Tower Mental Clinic

Tokyo, Japan

National Center of Neurology and Psychiatry

Tokyo, Japan

Nihonbashi Neuro Clinic

Tokyo, Japan

Shinjuku Neuro Clinic

Tokyo, Japan

Tokyo Women's Medical University, Adachi Medical Center

Tokyo, Japan

Yamaguchi Grand Medical Center

Yamaguchi, Japan

University of Yamanashi Hospital

Yamanashi, Japan

Yamanashi Prefectural Central Hospital

Yamanashi, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06579573

Related Trials

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

NCT076808421 location

Baker Gordon Syndrome Natural History Study

NCT063999521 location

A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

NCT067696591 location